Clinical Trial Update: Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial (NCT00094315) sponsored by NIDA to develop a human laboratory model for cocaine relapse prevention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine Use Disorder

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cocaine-Related Disorders | Phase 1 | Status: UNKNOWN